Transdigm Group INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Form 4: TransDigm Group COO Sells Shares
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, sold 4,100 shares of common stock on October 15, 2026.
NYSE
Robert J Small, a Director of TransDigm Group INC, reported multiple transactions in common stock on September 18, 2026.
NYSE
Peter Palmer, a Director of TransDigm Group INC, received 34 shares of common stock on September 18, 2026.
NYSE
W Nicholas Howley, a Director of TransDigm Group INC, received 126 shares of common stock on September 18, 2026.
NYSE
Irina Igorevna Krasik, a Director of TransDigm Group INC, received 13 shares of common stock on September 18, 2026.
NYSE
Robert J Small, a Director of TransDigm Group INC, received 52 shares of common stock on September 18, 2026.
NYSE
Michele Santana, a Director of TransDigm Group INC, received 34 shares of common stock on September 18, 2026.
NYSE
Gary E Mccullough, a Director of TransDigm Group INC, received 41 shares of common stock on September 18, 2026.
NYSE
Sean P Hennessy, a Director of TransDigm Group INC, received 46 shares of common stock on September 18, 2026.
NYSE
Michael Graff, a Director of TransDigm Group INC, received 34 shares of common stock on September 18, 2026.
NYSE
Jane M. Cronin, a Director of TransDigm Group INC, received 34 shares of common stock on September 18, 2026.
NYSE
David Barr, a Director of TransDigm Group INC, received 46 shares of common stock on September 18, 2026.
NYSE
Form 4: TransDigm Group COO Sells Shares
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, sold 3,900 shares of common stock on September 15, 2026.
NYSE
W Nicholas Howley, a Director of TransDigm Group INC, sold 10,132 shares of common stock on August 18, 2026.
NYSE
Form 4: TransDigm Group COO Sells Shares
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, sold 3,900 shares of common stock on August 17, 2026.
NYSE
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, reported a transaction in 3,900 shares of common stock on July 15, 2026.
NYSE
W Nicholas Howley, a Director of TransDigm Group INC, sold 10,132 shares of common stock on July 20, 2026.
NYSE
Form 4: TransDigm Group COO Sells Shares
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, sold 414 shares of common stock on July 15, 2026.
NYSE
Form 4: TransDigm Group COO Sells Shares
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, sold 3,486 shares of common stock on July 15, 2026.
NYSE
TransDigm Group Director W. Nicholas Howley files an amended Form 4 to correct administrative errors made by the filing agent, superseding previous duplicate filings.
NYSE
Form 4: TransDigm Director Sells Shares
W. Nicholas Howley, a Director at TransDigm Group Inc., reported the sale of common stock on May 18, 2026, through the W. Nicholas Howley Family Trust.
NYSE
Form 4: TransDigm Executive Sells Shares
Joel Reiss, Co-Chief Operating Officer of TransDigm Group Inc., reported the sale of common stock totaling 3,900 shares on May 15, 2026.
NYSE
Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group Inc. on April 20, 2026.
NYSE
TransDigm Group Co-Chief Operating Officer Joel Reiss exercised 3,900 stock options and subsequently sold the shares on April 15, 2026.
NYSE
TransDigm Group Director Peter Palmer acquired 30 shares of common stock valued at $36,439.80 in lieu of a semi-annual director fee.
NYSE
TransDigm Group Director Jane M. Cronin is scheduled to acquire 30 shares of common stock as part of her semi-annual director fee.
NYSE
TransDigm Group Director Sean Hennessy acquired 41 shares of common stock as part of his semi-annual director fee.
NYSE
TransDigm Group Director Gary McCullough acquired 37 shares of common stock in lieu of a semi-annual director fee, increasing his direct beneficial ownership to 952 shares.
NYSE
TransDigm Group Director David Barr acquired 41 shares of common stock valued at $1,214.66 per share as part of his semi-annual director fee.
NYSE
TransDigm Group Director Michael Graff acquired 30 shares of common stock at $1,214.66 per share as part of his semi-annual director fee.